Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Assets Average (2015 - 2026)

Mesoblast's (MEOBF) quarterly Assets Average came in at $777.7 million in Q2 2026, up 8.16% year-over-year from $719.0 million in Q2 2025, and down 0.74% quarter-over-quarter from $783.5 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Assets Average (2015 - 2026) Analysis & Trends

Mesoblast has disclosed Assets Average across 12 years of filings, most recently posting $777.7 million for Q2 2026.

  • In Q2 2026, Assets Average rose 8.16% year-over-year to $777.7 million; the TTM figure through Jun 2026 stood at $777.7 million (up 8.16% YoY), while the FY2026 annual figure was $778.9 million, up 7.15% from the prior year.
  • Assets Average came in at $777.7 million for Q2 2026 at Mesoblast, down from $783.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $783.5 million in Q4 2025 to a low of $659.3 million in Q1 2023.
  • Average Assets Average over 5 years is $692.9 million, with a median of $672.6 million recorded in 2022.
  • Year-over-year, Assets Average retreated 11.05% in 2022 and increased 18.49% in 2025.
  • Over 5 years, Assets Average stood at $676.3 million in 2022, then dropped by 0.95% to $669.8 million in 2023, then slipped by 1.29% to $661.2 million in 2024, then advanced by 18.49% to $783.5 million in 2025, then retreated by 0.74% to $777.7 million in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $777.7 million in Q2 2026, $783.5 million in Q4 2025, and $719.0 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Krystal Biotech 10.27 Bn 9.42 Bn 112.79 Mn 1.45 Bn
2 CRISPR Therapeutics AG 5.20 Bn 5.20 Bn - 2.69 Bn
3 Iovance Biotherapeutics 3.78 Bn 3.49 Bn 55.72 Mn 920.60 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.67 Bn
5 uniQure 3.06 Bn 3.06 Bn 5.49 Mn 881.90 Mn
6 Beam Therapeutics 2.68 Bn 2.68 Bn - 1.43 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 154.46 Mn
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn 3.18 Bn
9 Vericel 2.00 Bn 1.83 Bn 56.40 Mn 494.25 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - 777.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 777.69 Mn
Dec 31, 2025 783.50 Mn
Jun 30, 2025 719.00 Mn
Dec 31, 2024 661.24 Mn
Jun 30, 2024 669.72 Mn
Dec 31, 2023 669.85 Mn
Jun 30, 2023 659.93 Mn
Mar 31, 2023 659.25 Mn
Dec 31, 2022 676.28 Mn
Sep 30, 2022 673.32 Mn
Jun 30, 2022 671.92 Mn
Mar 31, 2022 693.06 Mn
Dec 31, 2021 713.13 Mn
Sep 30, 2021 733.27 Mn
Jun 30, 2021 755.42 Mn
Mar 31, 2021 726.72 Mn
Dec 31, 2020 699.94 Mn
Sep 30, 2020 723.09 Mn
Jun 30, 2020 699.70 Mn
Mar 31, 2020 678.01 Mn